Bernstein Initiates Coverage On Nuvalent with Outperform Rating, Announces Price Target of $189

Benzinga Newsdesk www.benzinga.com Positive 70.3%

Neg 0% Neu 0% Pos 70.3%

Bernstein analyst Jeffrey Walch initiates coverage on Nuvalent (NASDAQ:NUVL) with a Outperform rating and announces Price Target of $189.